INSM vs ROIV: stock comparison and AI forecast
Insmed Inc (INSM) and Roivant Sciences Ltd. (ROIV) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
INSM Insmed Inc
- Price
- $109.31 -21.9% · 6M
- Market Cap
- $23.87B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
ROIV Roivant Sciences Ltd.
- Price
- $35.89 +26.6% · 6M
- Market Cap
- $25.92B
- P/E Ratio
- –
- Size
- large-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- INSM and ROIV have similar market capitalizations ($23.87B and $25.92B).
- Over the last six months ROIV returned +26.6% and INSM -21.9%.
- INSM turns -39.9% of its revenue into net income, against -3535.0% for ROIV.
- INSM carries 2.07 times debt per unit of equity, against 0.09 times for ROIV.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | INSM | ROIV |
|---|---|---|
| Market Cap | $23.87B | $25.92B |
| P/B Ratio | 32.87x | 6.13x |
| EPS | $-2.01 | $-0.47 |
| Book Value/Share | $3.33 | $5.86 |
| Revenue/Share | $6.96 | $0.01 |
| FCF/Share | $-2.87 | $-1.14 |
Profitability & Margins
| Metric | INSM | ROIV |
|---|---|---|
| ROE | -83.4% | -6.3% |
| ROA | -27.2% | -5.0% |
| ROIC | -34.6% | -11.9% |
| Gross Margin | 84.4% | – |
| Operating Margin | -37.1% | -7914.8% |
| Net Margin | -39.9% | -3535.0% |
| EBT Margin | -39.4% | -3848.7% |
| Tax Rate | -1.3% | -43.0% |
Financial Health
| Metric | INSM | ROIV |
|---|---|---|
| Current Ratio | 2.86x | 16.72x |
| Quick Ratio | 2.59x | – |
| D/E Ratio | 2.07x | 0.09x |
| Financial Leverage | 3.07x | 1.25x |
| Interest Coverage | -6.7x | 35.9x |
| Working Capital | $1.11B | $4.46B |
Cash Flow
| Metric | INSM | ROIV |
|---|---|---|
| Operating Cash Flow | -$596M | -$816M |
| Free Cash Flow | -$628M | -$821M |
| Capital Spending | -$32M | -$5M |
| FCF/Sales | -41.3% | -10901.0% |
| CapEx/Sales | 2.1% | 61.0% |
Operational Efficiency
| Metric | INSM | ROIV |
|---|---|---|
| Asset Turnover | 0.68x | 0.00x |
| Receivables Turnover | 5.9x | – |
| Inventory Turnover | 1.4x | – |
| Fixed Assets Turnover | 14.0x | 0.7x |
| Days Sales Outstanding | 62 days | – |
| Days Inventory | 252 days | – |
| Payables Period | 130 days | – |
| Cash Conversion Cycle | 185 days | – |
Income Statement
| Metric | INSM | ROIV |
|---|---|---|
| Total Revenue | $1.52B | $8M |
| Operating Income | -$564M | -$596M |
| Net Income | -$606M | -$266M |
| R&D Expense | $944M | $731M |
| SG&A Expense | $960M | – |
| Cost of Goods Sold | $237M | – |
Dividend & Shareholder Information
| Metric | INSM | ROIV |
|---|---|---|
| Shares Outstanding | 218M | 722M |
INSM vs ROIV: stock comparison and AI forecast
Which is bigger, INSM or ROIV?
INSM and ROIV have similar market capitalizations ($23.87B and $25.92B).
Which stock performed better over the last six months, INSM or ROIV?
Over the last six months ROIV returned +26.6% and INSM -21.9%.
Which one does Intratio's AI model rank higher, INSM or ROIV?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.